Psoriasis Patient Treatment Preferences: Pill or Biologic?

Patients in these appointments are active and specific about what they want. The physician still shapes which attribute the choice turns on.

August is Psoriasis Action Month, so we thought we would share what psoriasis sounds like from inside the appointments.

On the surface, a patient with plaque psoriasis who is unsuccessful with topicals often arrives expecting the decision to be a pill or an injection. And in reality, administration does get a lot of early attention, but then conversation frequently moves on to other attributes before a treatment is decided: how well it works, how often it has to be taken, whether the patient is likely to keep taking it.

Launch messaging built around the route choice may correctly assume that patients walk in preferring the pill, but they should be wary not to over index on one attribute. What we hear in practice is a patient who is engaged, specific about what they want, while also entirely open to their doctor's guidance and recommendations.

The audio below is from real psoriasis treatment planning discussions, recorded through ZoomRx's HCP-Patient Conversation format. Hearing the patient in the room allows her reasoning to be visible to us.

A patient knows exactly what she wants, and route is not part of it

She names two attributes: stronger and no immune suppression, and stops. Whether those attributes are best met by a tablet or an injection is a question she has left open, and her physician is about to answer it for her.

This is the opening: the patient has laid out what she is looking for and taken an active role in the decision making. Arriving with attributes rather than a product leaves the physician informed to prioritize therapies on her behalf.

A different appointment. The physician asks, and the answer arrives with a condition

This patient expresses a real preference for oral administration and uses the opportunity he is given to introduce an important factor. Notice how unprompted, he requests something that does not modulate his immune system. That second condition is the one the patient is really focused on, he answered the question, and then took the opportunity to tell the doctor what actually matters.

What the route question does

This patient does the same thing. The unprompted mention of her adherence concern is a polite way of alerting her doctor that she expects to forget. Ask two patients a closed question about format and both of them answer it, then immediately hand over the criterion the question did not ask about.

Notice the opportunity this question creates. Route is the easy question: two options, no wrong answer, and a patient can answer it immediately without knowing anything clinical. Asking it brings her into the decision at the one point where she can contribute without needing specific training.

That matters more than it looks. She has been asked, and heard, and answered, and valuable context was added. Whatever they land on will be something she had a hand in. A patient who has been part of the decision is far less likely to second-guess it later, or to come back at the next visit wanting to reopen it.

What the route question does not do is settle the treatment. She names adherence, then half a minute later she is asking him what works best. Efficacy takes over as the criterion, and they are able to confidently move forward.

About thirty seconds later, the first patient has moved on

"What do you think will work best" is a distinct move from weighing preferences. A preference covers one attribute at a time: the needle, the dosing, the speed of clearance. Asking for what will work best is deference at a level above the individual attributes, a decision about who decides rather than about what is decided. She has made the specific preference she voiced clear and establishes that she and her doctor have quickly built trust between them.

The doctor answers the question she has now asked without clinical data, but with reassurance that he has chosen the appropriate class. Her adherence worry is never addressed, because by the time he answers, it is no longer the question on the table.

Why this matters for a launch

Patients should feel empowered to raise treatment questions with their physician, and these conversations show they are eager to. Ask them and they will tell you what they want, specifically and straight away.

What the audio also shows is how much influence the physician has over how that discussion runs. They choose which question gets asked and when, and which attribute the answer finally turns on. They do it in a way that leaves the patient inside the decision rather than talked out of one, and the two of them arrive at a plan they both agree on.

For a brand team, the lesson is not a message. It is that the decision-making dynamic cannot be assumed. A plan built on patients walking in and asking for the oral option is aimed at a moment that mostly is not happening. Who raises what, in what order, and what the choice finally turns on are all questions that we can help answer with real examples.

ZoomRx is a life sciences strategy consultancy that captures and analyzes real physician-patient conversations across therapeutic areas. Audio is de-identified and published with participant consent. To learn more about HCP-Patient Conversation research, contact our ZoomRx representative or visit zoomrx.com.